CardiacSense Ltd.
8
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Anonymized Data Collection From the CS6BP for Heart Arrythmias Measurements
Role: lead
Evaluation of CSF-3 in Performing ECG
Role: lead
Anonymized Data Collection From the CS6BP and Other Modalities for the Purpose Measurement of Blood Pressure
Role: lead
Accuracy of Pulse Oximeters With Profound Hypoxia
Role: lead
Data Collection of BP Values by CS6BP
Role: lead
Data Collection From the CardiacSense1 and Other Modalities for Developing a System for Monitoring of Respiratory Rate
Role: lead
Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation
Role: lead
Study to Evaluate the Performance of CardiacSense PPG Sensor
Role: lead
All 8 trials loaded